Spatial heterogeneity of cancer associated protein expression in immunohistochemically stained images as an improved prognostic biomarker.

Failmezger, Henrik; Hessel, Harald; Kapil, Ansh; Schmidt, Günter; Harder, Nathalie

Failmezger, Henrik; Hessel, Harald; Kapil, Ansh; Schmidt, Günter; Harder, Nathalie.

Afiliación

Failmezger H; Research & Development Early Oncology Translational Medicine, Computational Pathology, AstraZeneca Computational Pathology GmbH, Munich, Germany.
Hessel H; Research & Development Early Oncology Translational Medicine, Computational Pathology, AstraZeneca Computational Pathology GmbH, Munich, Germany.
Kapil A; Research & Development Early Oncology Translational Medicine, Computational Pathology, AstraZeneca Computational Pathology GmbH, Munich, Germany.
Schmidt G; Research & Development Early Oncology Translational Medicine, Computational Pathology, AstraZeneca Computational Pathology GmbH, Munich, Germany.
Harder N; Research & Development Early Oncology Translational Medicine, Computational Pathology, AstraZeneca Computational Pathology GmbH, Munich, Germany.

Front Oncol ; 12: 964716, 2022.

Article en En | MEDLINE | ID: mdl-36601480

Palabras clave

digital pathology; immunohistochemistry; prognostic biomarker; spatial heterogeneity; spatial statistics

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article País de afiliación: Alemania

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google